Director Ilana Lurie details initial equity stake in Wearable Devices (WLDS)

Rhea-AI Filing Summary

Wearable Devices Ltd. director Ilana Lurie filed an initial ownership report showing her equity stake in the company. She directly holds 37,500 Ordinary Shares. This amount includes 7,500 shares issuable from 2,500 restricted share units (RSUs) that begin vesting on October 10, 2026 and then in equal monthly installments through October 10, 2028, and 28,333 shares issuable from RSUs vesting in equal monthly installments of 833 shares through January 1, 2029, with each RSU representing one Ordinary Share.

She also holds a stock option covering 83 Ordinary Shares at an exercise price of 316.8000, which was granted on November 30, 2023, vests in monthly installments after an initial vesting on August 23, 2024, and expires on November 30, 2033.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Lurie Ilana

(Last) (First) (Middle)

5 HA-TNUFA STREET

(Street)

YOKNE'AM ILLIT 2066736

(City) (State) (Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Wearable Devices Ltd. [ WLDS ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	37,500(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock option (right to buy)	08/23/2024	11/30/2033	Ordinary Shares	83(2)	$316.8	D

Explanation of Responses:

1. Includes (i) 7,500 ordinary shares, no par value per share, of the Issuer (the "Ordinary Shares") issuable upon the vesting of 2,500 restricted share units ("RSUs") on October 10, 2026 and thereafter in equal monthly installments of 208 Ordinary Shares through October 10, 2028; and (ii) 28,333 Ordinary Shares issuable upon the vesting of RSUs in equal monthly installments of 833 Ordinary Shares through January 1, 2029. Each RSU represents the right to receive one Ordinary Share.

2. The options were granted on November 30, 2023 and vest as follows: 28 options vest on August 23, 2024 and the remaining 55 options vest in equal monthly installments of 2 Ordinary Shares thereafter.

	/s/ Ilana Lurie	03/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the Wearable Devices (WLDS) Form 3 for Ilana Lurie show?

The Form 3 shows director Ilana Lurie’s initial ownership in Wearable Devices Ltd., including 37,500 Ordinary Shares and a stock option for 83 shares. It details vesting schedules for her restricted share units and the option’s exercise terms.

How many Wearable Devices (WLDS) shares does Ilana Lurie beneficially own?

Ilana Lurie beneficially owns 37,500 Ordinary Shares of Wearable Devices Ltd. This figure includes shares issuable upon vesting of her restricted share units, which convert into Ordinary Shares over time according to the disclosed vesting schedules and terms.

What equity awards does Ilana Lurie hold in Wearable Devices (WLDS)?

Ilana Lurie holds restricted share units for 7,500 and 28,333 Ordinary Shares vesting in monthly installments through October 10, 2028 and January 1, 2029. She also holds a stock option for 83 Ordinary Shares with specified vesting and expiration dates.

What are the terms of Ilana Lurie’s stock option in Wearable Devices (WLDS)?

Her stock option covers 83 Ordinary Shares at an exercise price of 316.8000, granted on November 30, 2023. It vests partly on August 23, 2024, with remaining options vesting monthly, and expires on November 30, 2033 if not exercised.

How do Ilana Lurie’s RSUs in Wearable Devices (WLDS) vest over time?

One RSU grant converts into 7,500 shares, vesting on October 10, 2026 and then monthly through October 10, 2028. Another RSU grant converts into 28,333 shares, vesting in monthly installments of 833 shares through January 1, 2029.